A Study of Injection HB0025 in Patients With Advanced Solid Tumors

Clinical trial NCT04678908 · UNKNOWN

Trial details

NCT number: NCT04678908
Sponsor: Huabo Biopharm Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Tumor, Subjects

Start date: 2021-03-10
Primary completion: 2024-02-02
Enrollment: 154

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.